THERACLION (ALTHE.PA) Fundamental Analysis & Valuation

EPA:ALTHE • FR0010120402

Current stock price

0.5 EUR
-0.02 (-3.85%)
Last:

This ALTHE.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ALTHE.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALTHE has reported negative net income.
  • In the past year ALTHE has reported a negative cash flow from operations.
  • ALTHE had negative earnings in each of the past 5 years.
  • ALTHE had a negative operating cash flow in each of the past 5 years.
ALTHE.PA Yearly Net Income VS EBIT VS OCF VS FCFALTHE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M

1.2 Ratios

  • ALTHE has a worse Return On Assets (-45.47%) than 83.61% of its industry peers.
Industry RankSector Rank
ROA -45.47%
ROE N/A
ROIC N/A
ROA(3y)-35.17%
ROA(5y)-34.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALTHE.PA Yearly ROA, ROE, ROICALTHE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M 2M 3M 4M 5M

1.3 Margins

  • ALTHE has a Gross Margin of 54.01%. This is comparable to the rest of the industry: ALTHE outperforms 40.98% of its industry peers.
  • In the last couple of years the Gross Margin of ALTHE has remained more or less at the same level.
  • ALTHE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.68%
GM growth 5Y0.37%
ALTHE.PA Yearly Profit, Operating, Gross MarginsALTHE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. ALTHE.PA Health Analysis

2.1 Basic Checks

  • ALTHE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ALTHE has more shares outstanding
  • ALTHE has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ALTHE is higher compared to a year ago.
ALTHE.PA Yearly Shares OutstandingALTHE.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ALTHE.PA Yearly Total Debt VS Total AssetsALTHE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

  • ALTHE has an Altman-Z score of -0.03. This is a bad value and indicates that ALTHE is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -0.03, ALTHE is doing worse than 80.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.03
ROIC/WACCN/A
WACC7.82%
ALTHE.PA Yearly LT Debt VS Equity VS FCFALTHE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M -6M -8M

2.3 Liquidity

  • A Current Ratio of 2.40 indicates that ALTHE has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.40, ALTHE is in the better half of the industry, outperforming 67.21% of the companies in the same industry.
  • A Quick Ratio of 1.79 indicates that ALTHE should not have too much problems paying its short term obligations.
  • ALTHE has a better Quick ratio (1.79) than 73.77% of its industry peers.
Industry RankSector Rank
Current Ratio 2.4
Quick Ratio 1.79
ALTHE.PA Yearly Current Assets VS Current LiabilitesALTHE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. ALTHE.PA Growth Analysis

3.1 Past

  • The earnings per share for ALTHE have decreased strongly by -16.67% in the last year.
  • Looking at the last year, ALTHE shows a very strong growth in Revenue. The Revenue has grown by 215.63%.
  • Measured over the past years, ALTHE shows a very negative growth in Revenue. The Revenue has been decreasing by -21.49% on average per year.
EPS 1Y (TTM)-16.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.72%
Revenue 1Y (TTM)215.63%
Revenue growth 3Y-17.55%
Revenue growth 5Y-21.49%
Sales Q2Q%449.83%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALTHE.PA Yearly Revenue VS EstimatesALTHE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALTHE.PA Yearly EPS VS EstimatesALTHE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2018 2019 2020 2021 2022 2024 0 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

Find the best growth stocksShow best growing peers

0

4. ALTHE.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALTHE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALTHE.PA Price Earnings VS Forward Price EarningsALTHE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALTHE.PA Per share dataALTHE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALTHE.PA Dividend Analysis

5.1 Amount

  • No dividends for ALTHE!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALTHE.PA Fundamentals: All Metrics, Ratios and Statistics

THERACLION

EPA:ALTHE (4/24/2026, 7:00:00 PM)

0.5

-0.02 (-3.85%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-16
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners14.71%
Ins Owner ChangeN/A
Market Cap30.32M
Revenue(TTM)1.90M
Net Income(TTM)-5.25M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 15.94
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.11
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0.03
BVpS-0.04
TBVpS-0.06
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -45.47%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.01%
FCFM N/A
ROA(3y)-35.17%
ROA(5y)-34.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.68%
GM growth 5Y0.37%
F-Score2
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 80.63%
Cap/Sales 14.07%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.4
Quick Ratio 1.79
Altman-Z -0.03
F-Score2
WACC7.82%
ROIC/WACCN/A
Cap/Depr(3y)103.96%
Cap/Depr(5y)101.1%
Cap/Sales(3y)14.86%
Cap/Sales(5y)14.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.72%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)215.63%
Revenue growth 3Y-17.55%
Revenue growth 5Y-21.49%
Sales Q2Q%449.83%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-66.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-60.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-63.03%
OCF growth 3YN/A
OCF growth 5YN/A

THERACLION / ALTHE.PA Fundamental Analysis FAQ

What is the fundamental rating for ALTHE stock?

ChartMill assigns a fundamental rating of 1 / 10 to ALTHE.PA.


What is the valuation status for ALTHE stock?

ChartMill assigns a valuation rating of 0 / 10 to THERACLION (ALTHE.PA). This can be considered as Overvalued.


How profitable is THERACLION (ALTHE.PA) stock?

THERACLION (ALTHE.PA) has a profitability rating of 1 / 10.


Can you provide the financial health for ALTHE stock?

The financial health rating of THERACLION (ALTHE.PA) is 2 / 10.